NYTimes.com: Alzheimer’s Drug Slows Cognitive Decline in Key Study
12 views
Skip to first unread message
John Clark
Sep 28, 2022, 7:23:52 AM9/28/22
to 'Brent Meeker' via Everything List
Check out this article from The New York Times. Because I'm a subscriber, you can read it through this gift link without a subscription.
Alzheimer’s Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
https://www.nytimes.com/2022/09/27/business/alzheimers-drug-biogen-lecanemab.html?unlocked_article_code=rsZSU2JmKGGy-_Exjmzb0hw2EMcmJiJYnwt1zMbDTejar-vnrnx0fQcD2v-PMNM_UJcVnoAflP6dsRoEug0g5r9dtMCLUxH9-ds6NjY0w-GEKrFHIIjqJ14Iaey6_w0tFTT4TN7kPOskkIHKeVA63t-ksQLAuUAVKhi6_n2EXmucOinMb-tT5kfVPQyw5a7Mal4GtemM_52b1wWOXEAWXU6TM356bxYRlZfEHoz76nmCZI7PijXZSJUsw8oqOi7DhWw_ieq64o02NJrv94QCFsX9_A6v771VDrcnedpoRUmV_ZDQVeSm_bjBTRsgdL2bPwsEhpVDpuJ6AFGhXPlkgizMunPd8OMUrylq&smid=em-share
Alzheimer’s Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
https://www.nytimes.com/2022/09/27/business/alzheimers-drug-biogen-lecanemab.html?unlocked_article_code=rsZSU2JmKGGy-_Exjmzb0hw2EMcmJiJYnwt1zMbDTejar-vnrnx0fQcD2v-PMNM_UJcVnoAflP6dsRoEug0g5r9dtMCLUxH9-ds6NjY0w-GEKrFHIIjqJ14Iaey6_w0tFTT4TN7kPOskkIHKeVA63t-ksQLAuUAVKhi6_n2EXmucOinMb-tT5kfVPQyw5a7Mal4GtemM_52b1wWOXEAWXU6TM356bxYRlZfEHoz76nmCZI7PijXZSJUsw8oqOi7DhWw_ieq64o02NJrv94QCFsX9_A6v771VDrcnedpoRUmV_ZDQVeSm_bjBTRsgdL2bPwsEhpVDpuJ6AFGhXPlkgizMunPd8OMUrylq&smid=em-share
Pierz
Sep 28, 2022, 8:42:12 PM9/28/22
to Everything List
Always follow these types of results since my father had Alzheimer's... a .45 benefit on a scale of 18 does not exactly get me excited though.
Reply all
Reply to author
Forward
0 new messages